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Purpose: Mutations in the membrane-type frizzled-related protein (MFRP) gene have been identified in patients with
pathologic high hyperopia associated with nanophthalmos or microphthalmia. This study is to test if a mutation in MFRP
is responsible for physiologic high hyperopia.
Methods: DNA was prepared from venous leukocytes of 51 patients with physiologic high hyperopia (refraction of
spherical equivalent ≥+5.00 [diopters] D) and 96 controls (refraction of spherical equivalent between −0.50 D and +1.00
D). The coding regions and adjacent intronic sequence of MFRP were amplified by polymerase chain reaction (PCR) and
were then analyzed by cycle sequencing. Variations detected were further evaluated in normal controls and available
family members by heteroduplex- single-strand conformation polymorphism (SSCP) analysis or sequencing.
Results: The average spherical refractive error of patients was +8.41 D in the right eye (from +6.00 D to +16.5 D) and
was +8.76 D in the left eye (from +6.00 D to +16.5 D). Five novel heterozygous variations in MFRP,  c.55-14_55-
13insGTAT, c.496C>G, c.664C>A, c.669G>A, and c.770G>A, were identified. Of these, c.664C>A (p.Pro222Thr) and
c.669G>A (p.=) were not observed in the 96 normal controls. In addition, one known c.192C>G substitution and five
single nucleotide polymorphisms (SNPs; rs883247, rs3814762, rs36015759, rs2510143, and rs35885438) were detected.
Conclusions: Several novel variations in MFRP were detected in Chinese. Our results imply that MFRP is less likely to
play a major role in physiologic high hyperopia.
Hyperopia,  alternatively  termed  hypermetropia  or
farsightedness, is a common refractive error in children and
adults [1-3]. Hyperopia may be classified as low hyperopia
(+2.00 diopters [D] or less), moderate hyperopia (between
+2.25 D and +5.00 D), and high hyperopia (over +5.00 D)
[4]. The prevalence of hyperopia (+3 D or higher) in adults is
9.9%,  11.6%,  and  5.8%  in  the  USA,  Western  European
nations, and Australia, respectively [5]. Patients with high
hyperopia  may  suffer  from  blurred  vision,  asthenopia,
accommodative  dysfunction,  binocular  dysfunction,
amblyopia, strabismus, closure angle glaucoma, and retinal
detachment.  The  morphological  characteristics  of  high
hyperopia include a short eye axis, a narrow angle between
the cornea and iris, expansion of the choroidal vascular bed,
and a thickening of sclera connective tissue [6]. Most cases of
high hyperopia are physiologic high hyperopia that is not
associated with other ocular or systemic anomalies. However,
pathologic high hyperopia may present as a part of other eye
abnormalities  such  as  nanophthalmos,  microphthalmia,
anterior  segment  malformations,  and  Leber  congenital
amaurosis  [7-9]  while  there  are  also  numbers  of  high
hyperopia associated with systemic syndromes such as Down
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syndrome and fragile X syndrome [10,11]. Compared with
myopia, hereditary factors may play a more important role
than  environmental  factors  in  the  development  of  high
hyperopia [12,13]. Mutations in MFRP have been identified
to  be  responsible  for  nanophthalmos  2  (NNO2,  OMIM
609549)  and  microphthalmia  (OMIM  611040),  where
extremely high hyperopia (+8.00 D-+25.00 D) is a prominent
sign [6,8,14]. However, whether variations in MFRP play any
role in physiologic high hyperopia is still unclear, although
MFRP in 11 individuals with hyperopia (4 of the 11 with high
hyperopia) has been analyzed [14].
The  membrane-type  frizzled  related  protein  gene
(MFRP; OMIM 606227), located in 11q23, is comprised of
13  exons,  which  translate  into  a  579  amino  acid  protein.
Selectively expressed in the retinal pigment epithelium and
the ciliary body with C1q and tumor necrosis factor related
protein 5 (CTRP5) [6,15], the protein contains three domains,
a cysteine-rich domain (CRD) at the COOH-terminus, a type
II transmembrane domain, and an extracellular region with
two tandem-repeats of cubilin (CUB) at the NH2-terminus
[16]. The CRD can bind with Wnts (wingless type proteins),
which belong to a family of cell signaling molecules that are
possibly involved in eye development through mediating cell
growth [17]. Additionally, CUB is homologous with the low
density  lipoprotein  (LDL)  receptor.  Normal  function  of
MFRP is essential for the eye to reach its full size at birth and
is necessary for emmetropization, which is associated with the
regulation  of  ocular  axial  growth  [18].  Although  a  splice
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181mutation of Mfrp causes a recessive retinal degeneration in
the rd6 mouse [19,20], recessive mutations of MFRP have
been detected in humans with nanophthalmos [8] and have
been reported to be associated with an autosomal recessive
ophthalmic  syndrome  characterized  by  posterior
microphthalmos, retinitis pigmentosa, foveoschisis, and optic
disc  drusen  [21,22].  Since  the  simple  hyperopia  cases
represent a less severe form of a short axial length that is
similar to the delineation of nanophthalmos [18], MFRP may
also be the etiological factor of simple high hyperopia. The
identification of the causative or susceptibility genetic factors
involved  in  simple  high  hyperopia  will  have  clinical
implications for both ophthalmology and optometry.
Here, MFRP was analyzed in 51 Chinese patients with
physiologic high hyperopia to determine whether MFRP plays
a role in the development of high hyperopia.
METHODS
Patients  and  clinical  data:  A  previously  established  and
published  procedure  was  used  for  collecting  subjects  and
obtaining  informed  consent  [23].  This  study  followed  the
tenets of the Declaration of Helsinki and was approved by the
Institutional Review Board of Zhongshan Ophthalmic Center
(Guangzhou, China). Chinese subjects with high hyperopia
who met the following criteria were recruited: 1) they had
bilateral refraction errors of +5.00 D or higher (spherical
equivalent) and 2) they had no other known ocular or systemic
diseases. A group of 96 controls met the following criteria: 1)
bilateral refraction between –0.50 D and +1.00 D and 2) no
family history of hyperopia. The refractive error for all eyes
was measured with cycloplegic autorefraction after mydriasis
(Mydrin®-P,  a  compound  tropicamide;  Santen
Pharmaceutical  Co.  Ltd.,  Osaka,  Japan).  Ophthalmologic
examinations  were  performed  by  ophthalmologists  (Z.Y.,
Q.Z., and X.G.). Genomic DNA was prepared from the venous
blood of 51 unrelated patients with high hyperopia and of the
96 normal controls.
Variation  analysis:  Eight  pairs  of  primers  were  used  to
amplify  the  13  coding  exons  and  the  adjacent  intronic
sequence of MFRP (human genome build 36.2 NC_000011.8
for gDNA, NM_031433.1 for cDNA, and NP_113621.1 for
protein;  Table  1).  The  polymerase  chain  reaction  (PCR)
products  for  the  individual  exons  from  each  patient  were
sequenced with the ABI BigDye Terminator cycle sequencing
kit  version  3.1  (Applied  Biosystems,  Foster  City,  CA)
according to the manufacturer's recommendations using an
ABI  3100  Genetic  Analyzer  (Applied  Biosystems).
Sequencing  results  from  the  patients  as  well  as  MFRP
consensus sequences from the NCBI human genome database
(NM_031433.1) were imported into the SeqManII program of
the  Lasergene  package  (DNASTAR  Inc.,  Madison,
Wisconsin) and aligned to identify variations. Each variation
was  confirmed  by  bidirectional  sequencing.  The
nomenclature of the variation was performed according to the
directions recommended by the Human Genomic Variation
Society. Any detected novel variation in MFRP was further
evaluated  by  either  heteroduplex-SSCP  (single-strand
conformation  polymorphism)  analysis  [24]  or  by  direct
sequencing in available family members as well as in the 96
normal controls. Extra pairs of primers were designed for
heteroduplex-SSCP  analysis  (Table  2).  Five  variations
(rs36015759,  rs2510143,  c.55-14_55-13insGTAT,  c.
496C>G,  and  c.770G>A)  were  genotyped  and  tested  for
TABLE 1. PRIMERS USED FOR POLYMERASE CHAIN REACTION AMPLIFICATION AND SEQUENCING OF MFRP.
Exon               Primer sequence (5'-3')
Size of PCR product
(bp)                                        (°C)                                  Note
Annealing temperature
1,2 F-CTTTTCCCTCGGGTAGTAGA 466 60 GC buffer
  R-GTTGGCAGGTGGGGTTTTGAA
3,4 F-AGGACAGCATGAGGAATACC 504 62
  R-AACCCCACCCCGTCATCTTG
5 F-GAGAAGGGCCCAAGATGACG 405 63 GC buffer
  R-TCCCTGCCACTCCCTGATTC
6,7 F-TTGGGGGTTGAGAAAATAGG 601 58
  R-CTGGGCCAAAGAATGACTGA
8 F-ATCACCGCCAGCCCTATTG 281 62
  R-CATCCCCCGTCTGCTTGAT
9 F-GGTGCCCGGGATGAGACAG 267 62 GC buffer
  R-CCGGGGGTGGCAGACAGT
10,11 F-GCAGTGCCCCCTCAGTCAGC 511 64
  R-GTGGGCACCCAGCCTGCTC
12,13 F-CAGGCCACAGAGCCAGTGAG 548 63
  R-AGCCCTGACCGGCAAAAGAG
GC buffer was provided by Takara Biotechnology (Dalian) CO.Ltd (Liaoning,China) and designed for amplification of templates
having  complex secondary structure or high GC content. In the "Primer sequence" column, "F" indicates the forward sequence
and "R" indicates the reverse sequence.
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threshold of 0.05.
RESULTS
A total of 51 unrelated patients with high hyperopia were
recruited into our study. The average spherical refractive error
of patients was +8.41 diopters in the right eye (from +6.00 D
to +16.5 D) and was +8.76D in left eye (form +6.00D to +16.5
D). Direct sequencing identified 11 heterozygous variations in
MFRP where the following five variations were novel: c.55-
14_55-13insGTAT, c.496C>G, c.664C>A, c.669G>A, and c.
770G>A (Table 3 and Figure 1A). Except for c.664C>A and
c.669G>A, the rest of the novel variations were observed in
the normal controls by heteroduplex-SSCP analysis (Figure
1B). For the missense variation, c.664C>A (p.Pro222Thr),
which was identified in one patient, the threonine (a small,
hydrophobic amino acid carrying charge) took the place of
proline (a small amino acid), which resulted in a change at the
protein level with a residue weight of −1 (evaluated by amino
acid substitution matrices Blosum 62). The proline at position
222 is highly conserved for MFRP as demonstrated by an
analysis of six orthologs from different vertebrate species
(Figure  1C).  For  the  synonymous  variation,  c.669G>A,
observed in two patients, the substitution did not change the
amino  acid  or  transcript  splicing.  In  addition,  a  reported
substitution,  c.192C>G  [25],  and  five  SNPs  (rs883247,
rs3814762, rs36015759, rs2510143, and rs35885438) were
observed.  No  statistical  association  was  observed  for
variations  (rs36015759,  rs2510143,  c.55-14_
55-13insGTAT, c.496C>G, and c.770G>A) between high
hyperopes and controls.
DISCUSSION
Recently, MFRP was evaluated among 11 hyperopia patients.
Five novel variations were identified, but direct sequencing
and family-based association analysis of these variations did
not  implicate  MFRP  in  the  process  of  moderate  to  high
hyperopia [14]. We screened this gene in a larger cohort of
physiologic high hyperopia and identified five novel sequence
variations of MFRP from 51 patients. Three of these (c.55–
14_55–13insGTAT, c.496C>G, and c.770G>A) appeared to
be common MFRP polymorphisms because all of them were
screened not only in patients but also in normal controls. Two
variations, c.664C>A (missense) and c.669G>A (silent), were
detected in only patients with high hyperopia.
TABLE 2. PRIMERS USED FOR EVALUATING THE VARIATIONS BY HETERODUPLEX-SINGLE STRAND CONFORMATIONAL POLYMORPHISM ANALYSIS.
Variations                       Primer sequence (5'-3')




c.192C>G F-TGCCCTCAGCCCTCAAGTATC 340 66
R-CAGCCCAAGCAGCAGGAGGAG
c.55-14_55-13insGTAT      F-CTTTTCCCTCGGGTAGTAGA 344 62
R-GACGCTGTAGCTGGCATCCT
c.664C>A F-TCTCTGGCTGACCCTGCTCTT 152 60
c.669G>A R-AAACCAAATCCTTCCACACTGCT
c.770G>A F-TTGGGGGTTGAGAAAATAGG 283 60
R-TGGGTGGAGGGGAAGAAAGTG
In the "Primer sequence" column, "F" indicates the forward sequence and "R" indicates the reverse sequence.
TABLE 3. SEQUENCE VARIATIONS IN MFRP OBSERVED IN 51 PATIENTS WITH HYPEROPIA.
Variations Location Change                        Effect
Hyperopia
(n=51)                           (n=96)
Normal control
c.1–31G>A 5′ GGA-GAA rs883247 26 ND
c.55-14_55-13ins GTAT Intron 1 insertGTAT No effect 3 7*
c.192C>G Exon 3 CGC-CGG Arg-Arg 1 0
c.406G>A Exon 4 GTG-ATG rs3814762 20 ND
c.492C>T Exon 5 TAC-TAT rs36015759 20 36*
c.496C>G Exon 5 CCC-GCC Pro-Ala 1 3*
c.540T>C Exon 5 CAT-CAC rs2510143 51 95*
c.664C>A Exon 6 CCC-ACC Pro-Thr 1 0
c.669G>A Exon 6 ACG-ACA Thr-Thr 2 0
c.770G>A Exon 6 CGC-CAC Arg-His 1 2*
c.954G>A Exon 8 CTG-CTA rs35885438 1 ND
The novel variations are highlighted in bold. An asterisk indicates that no statistical difference was observed between patients
and controls. ND: no detected.
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183MFRP  has  already  been  screened  in  patients  with
different  kinds  of  inherited  eye  diseases  such  as
nanophthalmos  2  (NNO2,  OMIM  609549)  [26],  posterior
microphthalmia with retinitis pigmentosa, foveoschisis and
optic disc drusen (OMIM 611040) [21,22], retinopathy [27],
glaucoma [25,28], and ocular disease related to axial length
[14]. Besides six MFRP mutations identified in patients with
NNO2 or posterior microphthalmia with retinal degeneration,
Figure 1. The five novel variations identified in MFRP. A: The sequences of variations (indicated by an arrow) are shown on the left to compare
with the wild type sequences on the right. B: The variations, c.664C>A and c.669G>A, were not observed in normal controls (NC) by
heteroduplex-SSCP analysis. C: The mutation, c.664C>A (indicated by an arrow), changed a highly conserved residue from proline to
threonine.
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184many non-pathological variations were observed in MFRP.
Among the six causative MFRP mutations, four of them were
homozygous  (c.498insC,  c.498delC,  c.524T>C,  and  c.
1143insC), and two of them were compound heterozygous (c.
492delC and c.545C>T). Five of the mutations were located
in exon 5 (428–641 bp of the consensus coding sequence),
which led to an assumption that the tract of short peptide in
this region might play a role in the etiology of eye anomalies
[21].  We  identified  a  heterozygous  missense  variation,  c.
496C>G (p.Pro166Ala), but this variation was also observed
in normal controls and the clinically normal mother of the
patient with the variation. Although it is less possible for the
c.496C>G variation of MFRP to account for hyperopia, the
recognition of this missense variation in the short tract of exon
5 in MFRP will help further the understanding of the role of
this area in the function of MFRP.
A silent variation (c.669G>A) presented in MFRP of two
patients with high hyperopia, but none of the controls carried
this change. Although the substitution did not change the
encoded amino acid or splice method, it might affect the in
vivo stability of the mRNA or protein folding, which is what
has been observed for other silent variations in other systems
[29-31]. Therefore, it is a variation in MFRP that has the
potential  to  cause  hyperopia.  The  missense  variation,  c.
664C>A, resulted in a significant change at the amino acid
level as evaluated by Blosum 62 (−1), and this substitution
was not identified in the normal controls. Unfortunately, no
other family members of this patient were available for us to
perform  a  cosegregation  analysis  on  this  variation.  More
research  is  needed  to  reveal  the  effect  of  the  two  MFRP
variations on simple high hyperopia.
In conclusion, five novel sequence variations of MFRP
were identified in the Chinese population where two of these
novel  variations  were  only  present  in  patients  with
physiologic high hyperopia. Our results imply that MFRP is
not likely to play a major role in physiologic high hyperopia.
Further studies are needed to clarify this point.
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